MicroTech Medical (Hangzhou) Co., Ltd. (2235.HK)

4.000 0.000 (0.00%) At close: 04:08PM HKT

MicroTech Medical (Hangzhou) Co., Ltd.

No. 108 Liuze Street
Cangqian Street Yuhang District
Hangzhou
China

https://www.microtechmd.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 760

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Pan Zheng	Executive Chairman & CEO	1.17M	N/A	1971
Ms. Xiu Liu	Executive Director, Financial Controller & Secretary of the Board	784.95k	N/A	1980
Dr. Fei Yu	Executive Director and Director of R&D Department	1.04M	N/A	1982
Dr. Yonghui Shi	SVP, Chief Strategy & Development Officer, Joint Company Secretary and Executive Director	1.41M	N/A	1981
Ms. Fangling Xu	VP & Head of Administration Department	99.5k	N/A	1984
Mr. Duo Bo	Legal Officer	N/A	N/A	1992
Mr. Yi Lan	Vice President of Marketing	N/A	N/A	1971
Ms. Pik Man Chu	Joint Company Secretary	N/A	N/A	1997

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.

Description

MicroTech Medical (Hangzhou) Co., Ltd. engages in the research and development, manufacture, and commercialization of diabetes management medical devices and consumables in the People's Republic of China and internationally. The company's products include Equil Patch insulin pump systems, AiDEX continuous glucose monitoring systems, POCT analyzer systems, blood glucose monitoring systems, and closed-loop artificial pancreas. It is also involved in engineering and technology research experimentation and development activities. The company was incorporated in 2011 and is headquartered in Hangzhou, the People's Republic of China.

Corporate governance

MicroTech Medical (Hangzhou) Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.